Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 61,392 |
|
|||||
| News | - |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| LakeShore Biopharma Company Ltd | LSBPW | NASDAQ | Equity Warrant |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0254 | 46.52% | 0.08 | 18:58:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0545 | 0.0545 | 0.09 | 0.08 | 0.0546 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume |
|---|---|---|---|---|
| 46 | 61,392 | 0.0671283 | 4,121 | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 300 | 0.0548 | USD |
LakeShore Biopharma Company Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 10.39M | 190.23M | - | 573.42M | -433.47M | -2.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News LakeShore Biopharma
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
LSBPW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China. |
NASDAQ:LSBPW -
What is the current LakeShore Biopharma Company Ltd share price?
The current share price of LakeShore Biopharma Company Ltd is $ 0.08
How many LakeShore Biopharma Company Ltd shares are in issue?
LakeShore Biopharma Company Ltd has 190,227,000 shares in issue
What is the market cap of LakeShore Biopharma Company Ltd?
The market capitalisation of LakeShore Biopharma Company Ltd is USD 10.39M
What is the 1 year trading range for LakeShore Biopharma Company Ltd share price?
LakeShore Biopharma Company Ltd has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of LakeShore Biopharma Company Ltd?
The price to earnings ratio of LakeShore Biopharma Company Ltd is -1.14
What is the cash to sales ratio of LakeShore Biopharma Company Ltd?
The cash to sales ratio of LakeShore Biopharma Company Ltd is 0.86
What is the reporting currency for LakeShore Biopharma Company Ltd?
LakeShore Biopharma Company Ltd reports financial results in CNY
What is the latest annual turnover for LakeShore Biopharma Company Ltd?
The latest annual turnover of LakeShore Biopharma Company Ltd is CNY 573.42M
What is the latest annual profit for LakeShore Biopharma Company Ltd?
The latest annual profit of LakeShore Biopharma Company Ltd is CNY -433.47M
What is the registered address of LakeShore Biopharma Company Ltd?
The registered address for LakeShore Biopharma Company Ltd is BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK, DAXING DISTRICT, BEIJING
What is the LakeShore Biopharma Company Ltd website address?
The website address for LakeShore Biopharma Company Ltd is www.yishengbio.com.
Which industry sector does LakeShore Biopharma Company Ltd operate in?
LakeShore Biopharma Company Ltd operates in the PHARMACEUTICAL PREPARATIONS sector
